Androgen blockade

Phase 3Small molecule

AAbdenour Nabid

Androgen blockade is one of 28 small molecule programs targeting Radiation Therapy. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Radiation TherapyActive, not recruiting

Radiation TherapyPhase 3

Active, not recruiting

Competition

Competitive Landscape

27 competitors in Radiation Therapy

#DrugCompanyPhaseTrials

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

38 2

Adrucil

EElorac, Inc.

Phase 3

34 3

Eloxatin

Teva

Phase 3

14 4

Oncovin

Eli Lilly

Phase 3

5 5

Xeloda

EEngelhard Arzneimittel GmbH & Co.KG

Phase 3

17 6

Adriamycin

Pfizer

Phase 3

4 7

Imfinzi

AstraZeneca

Phase 3

3 8

Nubeqa

Bayer

Phase 3

1 9

Cosmegen

RRECORDATI GROUP

Phase 3

4 10

Taxol

Teva

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 3Active, not recruiting

Radiation Therapy

NCT00223145

Clinical

Trials by Indication[1]

Radiation Therapy1 trial

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

Active, not recruiting·AAbdenour Nabid·Phase 3·NCT00223145·600 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Androgen blockade. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Androgen blockade compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Androgen blockade. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Abdenour Nabid company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAbdenour Nabid

Androgen blockade

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Radiation Therapy1 trial

References

Drug Info

Quick Facts

Related News